Nd:YAG laser treatment in patients with prostatic adenocarcinoma stage A

摘要

This paper describes laser irradiation in the prostatic adenocarcinoma of stage A. Prostatic adenocarcinoma is an unsuspected prostatic tumor, incidentally discovered during an hystologic examination after TURP or adenectomy, limited to the prostate. Sixteen patients with hystological diagnosis of prostatic carcinoma of stage A (12 A1 and 4 A2) entered the trial. After ultrasound control of the reduced prostatic tissue to a thin residual capsule an endoscopic and percutaneous irradiation with endoscopic Nd:YAG laser was performed. Average follow-up is 18 months (range 6-48). All patients had negative biopsies. No tumor had progressed. There were no side effects, both potency and continence were unchanged. The results are promising and comparable to short-term results obtained with conventional treatment.